FMR CORP 13D and 13G filings for The Oncology Institute, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 11:50 am Sale |
2024-11-29 | 13G | The Oncology Institute, Inc. TOI |
FMR CORP | 0 0.000% |
-4,754,083 (Position Closed) |
Filing |
| 2023-07-10 10:20 am Sale |
2023-07-07 | 13G | The Oncology Institute, Inc. TOI |
FMR CORP | 4,754,083 6.309% |
-7,247,899 (-60.39%) |
Filing |
| 2023-02-09 12:01 pm Purchase |
2023-02-09 | 13G | The Oncology Institute, Inc. TOI |
FMR CORP | 12,001,982 16.590% |
1,982 (+0.02%) |
Filing |
| 2021-12-10 08:52 am Purchase |
2021-12-09 | 13G | The Oncology Institute, Inc. TOI |
FMR CORP | 12,000,000 12.467% |
12,000,000 (New Position) |
Filing |